Minerva Neurosciences (NERV) Cash from Investing Activities (2014 - 2026)
Minerva Neurosciences posted quarterly Cash from Investing Activities of -$45.3 million for Q1 2026, down 277335.4% on a QoQ basis from -$16326.0 in Q4 2022.
Minerva Neurosciences (NERV) has 9 years of Cash from Investing Activities data on file, last reported at -$45.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$45.3 million; the trailing twelve-month figure through Mar 2026 stood at -$45.3 million (changed N/A YoY), and the FY2022 full-year result was -$16326.0, changed N/A from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$45.3 million, down from -$16326.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$16326.0 in Q4 2022 and bottomed at -$45.3 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - | -45.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.29 Mn |
| Mar 31, 2026 | -45.29 Mn |
| Dec 31, 2022 | -16,326.00 |
| Dec 31, 2022 | -16,326.00 |
| Sep 30, 2020 | 3.00 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 4.50 Mn |
| Jun 30, 2020 | 4.50 Mn |
| Mar 31, 2020 | 17.03 Mn |
| Mar 31, 2020 | 17.03 Mn |
| Dec 31, 2019 | -2.31 Mn |
| Dec 31, 2019 | -2.31 Mn |
| Sep 30, 2019 | 19.58 Mn |
| Sep 30, 2019 | 19.58 Mn |
| Jun 30, 2019 | 7.37 Mn |
| Jun 30, 2019 | 7.37 Mn |
| Mar 31, 2019 | -10.55 Mn |
| Mar 31, 2019 | -10.55 Mn |
| Dec 31, 2018 | -27.43 Mn |
| Dec 31, 2018 | -27.43 Mn |
| Sep 30, 2018 | 29.50 Mn |
| Sep 30, 2018 | 29.50 Mn |
| Jun 30, 2018 | 36.10 Mn |
| Jun 30, 2018 | 36.10 Mn |
| Mar 31, 2018 | 31.32 Mn |
| Mar 31, 2018 | 31.32 Mn |
| Dec 31, 2017 | -23,869.00 |
| Dec 31, 2017 | -23,869.00 |
| Sep 30, 2017 | -79.80 Mn |
| Sep 30, 2017 | -79.80 Mn |
| Jun 30, 2017 | -10.89 Mn |
| Jun 30, 2017 | -10.89 Mn |
| Mar 31, 2017 | -16.48 Mn |
| Mar 31, 2017 | -16.48 Mn |
| Sep 30, 2016 | 8.38 Mn |
| Sep 30, 2016 | 8.38 Mn |
| Jun 30, 2016 | 1.40 Mn |
| Jun 30, 2016 | 1.40 Mn |
| Mar 31, 2016 | 8.04 Mn |
| Mar 31, 2016 | 8.04 Mn |
| Dec 31, 2015 | 4.05 Mn |
| Dec 31, 2015 | 4.05 Mn |
| Sep 30, 2015 | 827,975.00 |
| Sep 30, 2015 | 827,975.00 |
| Jun 30, 2015 | -23.20 Mn |
| Jun 30, 2015 | -23.20 Mn |
| Mar 31, 2015 | -4,986.00 |
| Mar 31, 2015 | -4,986.00 |
| Dec 31, 2014 | -46,884.00 |
| Dec 31, 2014 | -46,884.00 |
| Sep 30, 2014 | -33,739.00 |
| Sep 30, 2014 | -33,739.00 |
| Mar 31, 2014 | 1.17 Mn |
| Mar 31, 2014 | 1.17 Mn |